KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Change in Cash (2016 - 2025)

Historic Change in Cash for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $62.3 million.

  • National Health Investors' Change in Cash rose 711087.96% to $62.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.9 million, marking a year-over-year increase of 887170.33%. This contributed to the annual value of $1.9 million for FY2024, which is 3921.32% down from last year.
  • National Health Investors' Change in Cash amounted to $62.3 million in Q3 2025, which was up 711087.96% from -$118.0 million recorded in Q2 2025.
  • National Health Investors' Change in Cash's 5-year high stood at $110.8 million during Q1 2025, with a 5-year trough of -$118.0 million in Q2 2025.
  • In the last 5 years, National Health Investors' Change in Cash had a median value of $864000.0 in 2024 and averaged $1.9 million.
  • Examining YoY changes over the last 5 years, National Health Investors' Change in Cash showed a top increase of 711087.96% in 2025 and a maximum decrease of 340033.58% in 2025.
  • Quarter analysis of 5 years shows National Health Investors' Change in Cash stood at -$10.7 million in 2021, then grew by 4.78% to -$10.2 million in 2022, then surged by 160.03% to $6.1 million in 2023, then soared by 42.68% to $8.7 million in 2024, then soared by 613.25% to $62.3 million in 2025.
  • Its Change in Cash was $62.3 million in Q3 2025, compared to -$118.0 million in Q2 2025 and $110.8 million in Q1 2025.